Ichorcumab

DB18930InvestigationalProtein Based Therapies

Ichorcumab is under investigation in clinical trial NCT03251482 (A Study to Evaluate the Safety and Efficacy of Intravenous JNJ-64179375 Versus Oral Apixaban in Participants Undergoing Elective Total Knee Replacement Surgery).

Mechanism: Pharmacologically active on Prothrombin
Curator reviewed
Code names: JNJ-375 · JNJ-64179375 · JNJ-9375

Resolves to

Compound

UNIIUW0H6X9FSQCAS2589583-20-8

Targets

P00734F2

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Ichorcumab, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account